Sue Bailey, Director at Emergent BioSolutions Inc. (EBS), sold 17,717 shares at $69.62 ($1.2M) on 2018-11-27, disclosed to the SEC on 2018-11-29.
Open-market sale of $1.2M EBS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $69.62 | 1,579 | $110K | 8.9% |
| 2 | $69.62 | 3,158 | $220K | 17.8% |
| 3 | $69.62 | 4,736 | $330K | 26.7% |
| 4 | $69.62 | 8,244 | $574K | 46.5% |
| Total | $69.62 avg | 17,717 | $1.2M | 100% |
| Filing → |
| EBS | SELL | 2020-06-05 | $466K | — | Filing → |
| EBS | SELL | 2020-03-02 | $748K | — | Filing → |
| EBS | SELL | 2019-12-13 | $895K | — | Filing → |